Operating Margin of iTeos Therapeutics, Inc. from 31 Dec 2021 to 31 Dec 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
iTeos Therapeutics, Inc. quarterly and annual Operating Margin in % history and change rate from 31 Dec 2021 to 31 Dec 2024.
  • iTeos Therapeutics, Inc. Operating Margin for the quarter ending 31 Dec 2024 was -456%, a 62% increase year-over-year.
  • iTeos Therapeutics, Inc. annual Operating Margin for 2024 was -456%, a 62% increase from 2023.
  • iTeos Therapeutics, Inc. annual Operating Margin for 2023 was -1200%, a 2642% decline from 2022.
  • iTeos Therapeutics, Inc. annual Operating Margin for 2022 was 47%, a 34% decline from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)

iTeos Therapeutics, Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q4 2024 -456% +744% +62% 01 Oct 2024 31 Dec 2024
Q3 2024 -430% -289% -206% 01 Jul 2024 30 Sep 2024
Q2 2024 -414% -338% -445% 01 Apr 2024 30 Jun 2024
Q4 2023 -1200% -1247% -2642% 01 Oct 2023 31 Dec 2023
Q3 2023 -141% 01 Jul 2023 30 Sep 2023
Q2 2023 -76% 01 Apr 2023 30 Jun 2023
Q1 2023 -15% 01 Jan 2023 31 Mar 2023
Q4 2022 47% 01 Oct 2022 31 Dec 2022

iTeos Therapeutics, Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2024 -456% +744% +62% 01 Jan 2024 31 Dec 2024
2023 -1200% -1247% -2642% 01 Jan 2023 31 Dec 2023
2022 47% -24% -34% 01 Jan 2022 31 Dec 2022
2021 71% 01 Jan 2021 31 Dec 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.